Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Herbal blend shows promise for chronic fatigue in new trial

NCT ID NCT06245642

Symptom relief Sponsor: Heilongjiang Quanle Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed Phase 4 trial tested two herbal granules, Compound Ciwujia and Guipi, in 235 adults with chronic fatigue syndrome. Participants took the granules for 6 weeks. The main goal was to see if fatigue scores improved. The study also looked at quality of life and traditional Chinese medicine symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Compound Ciwujia Granules (herbal granules) and Guipi Granules (herbal granules)
What this could lead to
If it works, this could offer a new herbal option to ease fatigue and improve quality of life for people with chronic fatigue syndrome.
What could go wrong
This is a completed Phase 4 trial, but results are not yet published. The study uses traditional Chinese medicine concepts, which may not be accepted by all doctors. The improvement measured is based on a symptom scale, not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

235 people

The number who actually took part.

Started

Mar 2024

Finished

Jan 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Meet the diagnostic criteria of Western medicine for chronic fatigue syndrome; * Meet the diagnostic criteria of spleen and kidney deficiency syndrome or heart and spleen deficiency syndrome of traditional Chinese medicine; * Chalder scale score greater than 12 points; * Age 18-70 years old, gender is not limited; * Agree to participate in this clinical study, voluntarily sign informed consent, and agree to participate in visits, examinations, and treatments according to the requirements of the research protocol. Exclusion Criteria: * Combined with mental disorders such as severe anxiety and severe depression; * Secondary fatigue caused by drugs or other reasons; * Patients with serious primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system, malignant tumors, and other serious complications; Abnormal liver and kidney function ALT, AST≥ 1.5 times the upper limit of normal value, Cr \> the upper limit of normal value; * Women who are pregnant, breastfeeding or who may become pregnant in the study and cannot use effective contraception; * Have received relevant treatment and may affect the observed effect indicators; * Suspected to have a history of drug abuse or other patients who do not meet the eligibility criteria; * Allergic physique and allergic to the drug; * Uncontrolled hypertension (DBP \> 100mmHg or SBP \> 160 mmHg); * Diabetic patients; * Those that the researcher thinks are not suitable for participating in this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic fatigue syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myalgic encephalomeyelitis/chronic fatigue syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic fatigue syndrome

Contacts and locations

Locations

  • Shanghai Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

    Shanghai, Shanghai Municipality, 200000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.